Sjögren-szindróma: vizsgálatok itt: Kanada
4 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleTwo Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Where
- Rimouski, Sherbrooke, Sydney
- Életkor
- 18 év and over
- People
- 570 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07621809 · EU 2025-522271-29-00 - 2. fázisTaking peopleA Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
- Where
- Rimouski, Sherbrooke, Trois-Rivières
- Életkor
- 18 év to 100 év
- People
- 344 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07737743 · EU 2025-524513-92-00 - 1. fázisTaking peopleTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03816345 - 3. fázisTaking peopleA Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- Where
- Trois-Rivières
- Életkor
- 18 év and over
- People
- 844 worldwide
- Run by
- Amgen
See details and how to joinNCT06747949 · EU 2024-517513-32-00